Phase 2a Study of AR882 Alone and in Combination With Febuxostat or Allopurinol in Gout Patients

Key Inclusion Criteria: * History of gout * sUA \> 7 mg/dL * Estimated Glomerular Filtration Rate (eGFR) ≥ 60 mL/min/1.73m2 Key Exclusion Criteria: * Malignancy within 5 years, except for successfully treated basal or squamous cell carcinoma of the skin * History of cardiac abnormalities * Active peptic ulcer disease or active liver disease * History of kidney stones * Allergy or intolerance to colchicine, febuxostat, and allopurinol